LeMaitre Vascular Return on Tangible Equity 2010-2024 | LMAT
Current and historical return on tangible equity values for LeMaitre Vascular (LMAT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| LeMaitre Vascular Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $0.04B | $0.24B | 19.98% |
| 2024-09-30 | $0.04B | $0.23B | 19.64% |
| 2024-06-30 | $0.04B | $0.22B | 19.34% |
| 2024-03-31 | $0.03B | $0.20B | 18.26% |
| 2023-12-31 | $0.03B | $0.19B | 17.00% |
| 2023-09-30 | $0.03B | $0.18B | 16.67% |
| 2023-06-30 | $0.03B | $0.17B | 15.63% |
| 2023-03-31 | $0.02B | $0.16B | 13.82% |
| 2022-12-31 | $0.02B | $0.16B | 14.33% |
| 2022-09-30 | $0.02B | $0.15B | 14.87% |
| 2022-06-30 | $0.02B | $0.14B | 16.82% |
| 2022-03-31 | $0.03B | $0.14B | 23.03% |
| 2021-12-31 | $0.03B | $0.14B | 28.27% |
| 2021-09-30 | $0.03B | $0.13B | 37.97% |
| 2021-06-30 | $0.03B | $0.06B | 58.00% |
| 2021-03-31 | $0.03B | $0.05B | 62.89% |
| 2020-12-31 | $0.02B | $0.05B | 46.32% |
| 2020-09-30 | $0.02B | $0.03B | 35.56% |
| 2020-06-30 | $0.02B | $0.02B | 23.94% |
| 2020-03-31 | $0.02B | $0.09B | 20.22% |
| 2019-12-31 | $0.02B | $0.08B | 21.05% |
| 2019-09-30 | $0.02B | $0.09B | 21.92% |
| 2019-06-30 | $0.02B | $0.10B | 21.47% |
| 2019-03-31 | $0.02B | $0.09B | 26.36% |
| 2018-12-31 | $0.02B | $0.09B | 26.98% |
| 2018-09-30 | $0.02B | $0.08B | 25.30% |
| 2018-06-30 | $0.02B | $0.09B | 27.16% |
| 2018-03-31 | $0.02B | $0.08B | 24.00% |
| 2017-12-31 | $0.02B | $0.08B | 24.64% |
| 2017-09-30 | $0.02B | $0.07B | 25.40% |
| 2017-06-30 | $0.01B | $0.07B | 23.24% |
| 2017-03-31 | $0.01B | $0.06B | 20.60% |
| 2016-12-31 | $0.01B | $0.05B | 19.05% |
| 2016-09-30 | $0.01B | $0.06B | 19.05% |
| 2016-06-30 | $0.01B | $0.06B | 18.35% |
| 2016-03-31 | $0.01B | $0.06B | 17.48% |
| 2015-12-31 | $0.01B | $0.05B | 16.49% |
| 2015-09-30 | $0.01B | $0.05B | 15.22% |
| 2015-06-30 | $0.01B | $0.05B | 13.64% |
| 2015-03-31 | $0.01B | $0.04B | 11.24% |
| 2014-12-31 | $0.00B | $0.04B | 9.47% |
| 2014-09-30 | $0.00B | $0.04B | 7.50% |
| 2014-06-30 | $0.00B | $0.05B | 7.89% |
| 2014-03-31 | $0.00B | $0.04B | 8.57% |
| 2013-12-31 | $0.00B | $0.04B | 11.43% |
| 2013-09-30 | $0.00B | $0.03B | 11.51% |
| 2013-06-30 | $0.00B | $0.04B | 11.19% |
| 2013-03-31 | $0.00B | $0.04B | 11.11% |
| 2012-12-31 | $0.00B | $0.03B | 8.22% |
| 2012-09-30 | $0.00B | $0.04B | 5.37% |
| 2012-06-30 | $0.00B | $0.04B | 5.41% |
| 2012-03-31 | $0.00B | $0.04B | 5.41% |
| 2011-12-31 | $0.00B | $0.04B | 5.41% |
| 2011-09-30 | $0.00B | $0.04B | 10.81% |
| 2011-06-30 | $0.01B | $0.04B | 13.42% |
| 2011-03-31 | $0.01B | $0.04B | 16.33% |
| 2010-12-31 | $0.01B | $0.04B | 19.44% |
| 2010-09-30 | $0.01B | $0.04B | 17.02% |
| 2010-06-30 | $0.01B | $0.04B | 14.71% |
| 2010-03-31 | $0.00B | $0.03B | 12.12% |
| 2009-12-31 | $0.00B | $0.03B | 3.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.294B | $0.193B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |